Beyond Burritos and Lumpia: Ethnic Identity as a Difference in Preservice Teacher Education

Teachers play a pivotal role in society. On a daily basis they influence the futures of the children they encounter. Not only do they teach children how to read and write butteachers are also charged with the task of creating responsible citizens who should think critically about society. Teacher educators, and specifically those individuals charged with the task of preparing preservice teachers, have responsibilities similar to teachers in the field. Education, on any level, ought to be a transformative process. Thus, the preparation of teachers as instruments of social change ought to be a central focus in preservice teacher education programs. Teacher educators, as well as elementary and secondary mentor school teachers, are agents who have the potential to guide preservice teachers to think critically about educational structures that either promote or hinder the development of social equality in schools. Our views are corroborated by scholars such as Gloria Ladson-Billings who states that teacher education programs throughout the nation have coupled their efforts at reform with revised programs committed to social justice and equity (1995, p. 466)

Feeling (Mis)Understood and Intergroup Friendships in Interracial Interactions

The present research investigated whether having out-group friends serves as a buffer for feeling misunderstood in interracial interactions. Across three experience sampling studies, we found that among ethnic minorities who have few White friends or are not interacting with White friends, daily interracial interactions are associated with feeling less understood. By contrast, we found that among ethnic minorities who have more White friends or are interacting with White friends, the relationship between daily interracial interactions and feeling understood is not significant. We did not find similar results for Whites; that is, having ethnic minority friends did not play a role in the relationship between daily interracial interactions and feeling understood. Together, these studies demonstrate the beneficial effects of intergroup friendships for ethnic minorities

Effects of the inclusion of sunflower hulls in the diet on growth performance and digestive tract traits of broilers and pullets fed a broiler diet from zero to 21 d of age. A comparative study

The effects of including 3% sunflower hulls (SFH) in the diet on growth performance, nutrient retention (TTAR), and gastrointestinal tract (GIT) traits were studied in chicks from zero to 21 d of age. Four treatments that resulted from the combination of 2 chicken lines (female broilers vs. brown pullets) and 2 levels of SFH (zero vs. 3%) were used. The control diet contained 2,980 kcal AMEn/kg, 1.25% digestible Lys, and 8.7% neutral detergent fiber. The experimental diet included 3% SFH at the expense (wt:wt) of the whole diet. Growth performance, TTAR of nutrients, and the AMEn of the diet were greater (P = 0.097 to P < 0.001) in broilers than in pullets. In absolute terms, all the organs of the GIT were heavier (P < 0.001) and the small intestine and cecum were longer (P < 0.001) in broilers than in pullets. At 21 d of age, however, the relative weight (% BW) of all the organs of the GIT (P < 0.001) and the relative length (cm/kg BW) of the small intestine and cecum (P < 0.01) were greater in pullets. Gizzard pH (P < 0.001), total short chain fatty acids concentration in the cecum (P = 0.098), and villus height (P < 0.001) and crypt depth (P < 0.05) of the ileum mucosa were higher in broilers. The inclusion of SFH increased (P < 0.05) the AMEn content of the diet but did not affect bird performance, moisture content of the excreta, or the concentration and profile of fatty acids in the cecum. Dietary SFH increased gizzard weight and reduced gizzard pH (P < 0.001) at both ages. In conclusion, broilers had better growth performance, nutrient retention, and ileum absorptive capacity than pullets. The inclusion of 3% SFH at the expense of the control diet did not have any negative effect on chick performance and, in fact, increased gizzard weight, reduced gizzard pH, and improved the energy content of the diet

Cardiac resynchronization therapy and valvular cardiomyopathy after corrective surgery

Cardiac resynchronization therapy (CRT) has been shown to have clinical benefits in certain groups of patients with advanced heart failure (HF). However, patients with valvular cardiomyopathy are underrepresented in randomized clinical studies. The aim of this study was to assess the medium-term (i.e., at 6 months) effects of CRT in patients with HF exclusively due to valvular disease. The study included 40 consecutive patients who underwent CRT device implantation. At 6 months, there were improvements in functional class, left ventricular remodeling, and intraventricular dyssynchrony parameters in treated patients. In this particular subgroup of patients, the benefits of CRT were similar to those observed in patients with HF due to other etiologies

Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts.

Copyright: 2013 Hermann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.PURPOSE: In spite of intense research efforts, pancreatic ductal adenocarcinoma remains one of the most deadly malignancies in the world. We and others have previously identified a subpopulation of pancreatic cancer stem cells within the tumor as a critical therapeutic target and additionally shown that the tumor stroma represents not only a restrictive barrier for successful drug delivery, but also serves as a paracrine niche for cancer stem cells. Therefore, we embarked on a large-scale investigation on the effects of combining chemotherapy, hedgehog pathway inhibition, and mTOR inhibition in a preclinical mouse model of pancreatic cancer. EXPERIMENTAL DESIGN: Prospective and randomized testing in a set of almost 200 subcutaneous and orthotopic implanted whole-tissue primary human tumor xenografts. RESULTS: The combined targeting of highly chemoresistant cancer stem cells as well as their more differentiated progenies, together with abrogation of the tumor microenvironment by targeting the stroma and enhancing tissue penetration of the chemotherapeutic agent translated into significantly prolonged survival in preclinical models of human pancreatic cancer. Most pronounced therapeutic effects were observed in gemcitabine-resistant patient-derived tumors. Intriguingly, the proposed triple therapy approach could be further enhanced by using a PEGylated formulation of gemcitabine, which significantly increased its bioavailability and tissue penetration, resulting in a further improved overall outcome. CONCLUSIONS: This multimodal therapeutic strategy should be further explored in the clinical setting as its success may eventually improve the poor prognosis of patients with pancreatic ductal adenocarcinoma

EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma

Ewing sarcoma is characterized by chromosomal translocations fusing the EWS gene with various members of the ETS family of transcription factors, most commonly FLI1. EWS-FLI1 is an aberrant transcription factor driving Ewing sarcoma tumorigenesis by either transcriptionally inducing or repressing specific target genes. Herein, we showed that Sprouty 1 (SPRY1), which is a physiological negative feedback inhibitor downstream of fibroblast growth factor (FGF) receptors (FGFRs) and other RAS-activating receptors, is an EWS-FLI1 repressed gene. EWS-FLI1 knockdown specifically increased the expression of SPRY1, while other Sprouty family members remained unaffected. Analysis of SPRY1 expression in a panel of Ewing sarcoma cells showed that SPRY1 was not expressed in Ewing sarcoma cell lines, suggesting that it could act as a tumor suppressor gene in these cells. In agreement, induction of SPRY1 in three different Ewing sarcoma cell lines functionally impaired proliferation, clonogenic growth and migration. In addition, SPRY1 expression inhibited extracellular signal-related kinase/mitogen-activated protein kinase (MAPK) signaling induced by serum and basic FGF (bFGF). Moreover, treatment of Ewing sarcoma cells with the potent FGFR inhibitor PD-173074 reduced bFGF-induced proliferation, colony formation and in vivo tumor growth in a dose-dependent manner, thus mimicking SPRY1 activity in Ewing sarcoma cells. Although the expression of SPRY1 was low when compared with other tumors, SPRY1 was variably expressed in primary Ewing sarcoma tumors and higher expression levels were significantly associated with improved outcome in a large patient cohort. Taken together, our data indicate that EWS-FLI1-mediated repression of SPRY1 leads to unrestrained bFGF-induced cell proliferation, suggesting that targeting the FGFR/MAPK pathway can constitute a promising therapeutic approach for this devastating disease.FC-A, LG-G, JCL, AS, PG-M, SEL-P, SM and JA are supported by Asociación Pablo Ugarte and Miguelañez SA, ASION-La Hucha de Tomás, Fundación La Sonrisa de Alex and Instituto de Salud Carlos III (PI12/00816 and Spanish Cancer Network RTICC RD12/0036/0027). TGPG is supported by a grant from ‘Verein zur Förderung von Wissenschaft und Forschung an der Medizinischen Fakultät der LMU München (WiFoMed)’, the Daimler and Benz Foundation in cooperation with the Reinhard Frank Foundation, by LMU Munich’s Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative, the ‘Mehr LEBEN für krebskranke Kinder—Bettina-Bräu-Stiftung’, the Walter Schulz Foundation, the Fritz Thyssen Foundation (FTH-40.15.0.030MN) and by the German Cancer Aid (DKH-111886 and DKH-70112257). The ‘Genetics and Biology of Cancers’ team (TGPG, DS and OD) is supported by grants from the Ligue Nationale Contre Le Cancer (Equipe labellisée). This work was also supported by the European PROVABES, ASSET and EEC FP7 grants. We also thank the following associations for their invaluable support: the Société Française des Cancers de l’Enfant, Courir pour Mathieu, Dans les pas du Géant, Olivier Chape, Les Bagouzamanon, Enfants et Santé and les Amis de Claire. We thank Dr S Navarro (University of Valencia, Valencia, Spain) and Dr TJ Triche (Children’s Hospital Los Angeles, Los Angeles, USA) for providing us with Ewing sarcoma cell lines A4573 and TTC-466, respectively.S

In situ investigation of the mechanochemically promoted Pd–Ce interaction under stoichiometric methane oxidation conditions

The optimization of the supported Pd phase for CH4 activation on Pd/CeO2 catalysts has been a matter of great interest in the recent literature, aiming at the design of efficient methane abatement catalysts for Natural Gas fueled Vehicles (NGVs). Under lean conditions, a mixed Pd0 /PdO combination has been indicated as exhibiting the best performance, while controversial results have been reported under stoichiometric conditions depending on the support oxide, where either Al2O3 or zeolite-based supports are usually considered. Here, by means of synchrotron-based in situ NAP-XPS and XRD measurements, we follow the evolution of Pd species on Pd/CeO2 samples prepared by dry mechanochemical synthesis (M) under stoichiometric CH4 oxidation feed, unravelling a stable Pd0 /Pd2+ arrangement in a close to 1 : 1 ratio as the most active palladium state for CH4 activation when excess oxygen is not available, in contrast to what was reported for Pd/alumina materials, where metallic Pd0 nanoparticles showed the highest activity. The combination of NAP-XPS analysis and activity test results highlights the promotional effect of the Pd–Ce interaction, resulting in enhanced oxygen transfer and improved activity and stability of the Pd/CeO2 catalyst prepared by a novel mechanochemical approach even under low O2 content, large excess of water vapor (10 vol%) and high temperature exposure (4700 1C)

Quimioembolización en el hepatocarcinoma. Análisis de supervivencia en 37 pacientes en el HCU Lozano Blesa

Objetivo: Valorar la supervivencia de los pacientes con hepatocarcinoma (HCC) tratado mediante 1, 2 o más de 2 sesiones de quimioembolización transarterial (transarterial chemoembolization, TACE) en el Hospital Clínico Universitario (HCU) Lozano Blesa (febrero 2010 - mayo 2015). Materiales y Métodos: Se realizó una revisión bibliográfica del HCC y de la TACE, así como revisión de la base de datos del HCU de 38 pacientes con HCC tratados con TACE, valorando la supervivencia en función del número de sesiones realizadas y la respuesta al tratamiento mediante pruebas de imagen. Resultados: El número mínimo de sesiones de TACE fue 1 y un 50 % de los pacientes habían recibido terapia complementaria a la TACE. Tras la segunda TACE, se valoró la respuesta al tratamiento mediante los criterios mRECIST (modified Response Evaluation Criteria in Solid Tumors), contando con un total de 33 pacientes, obteniéndose en un 45 % una respuesta completa. En aquellos pacientes que recibieron más de 2 TACEs (27), se produjo respuesta completa en el 41 %. La supervivencia fue mayor en aquellos pacientes que recibieron 2 o más de 2 TACEs respecto a los que recibieron 1 sola sesión. Se apreciaron diferencias estadísticamente significativas en la supervivencia de los pacientes que se sometieron a TACE como tratamiento único o TACE más TOH (Trasplante Ortotópico Hepático); sin embargo no se detectaron diferencias significativas en los pacientes que recibieron TACE junto con tratamiento ablativo respecto a los que recibieron TACE. Conclusiones: La TACE mejora la supervivencia de los pacientes en estadio B de la BCLC (Barcelona Clinic Liver Cancer) o estadio A no candidatos a cirugía ni ablación y ayuda a evitar la progresión de la enfermedad en aquellos que se encuentran en lista de espera para TOH

Cystic Echinococcosis: Chronic, Complex, and Still Neglected

Cystic echinococcosis is a most clinically neglected parasitic disease that urgently needs attention. A valuable tool for diagnosing, staging, and following up patients, ultrasound, is readily available. Four management procedures, surgery, percutaneous sterilization techniques, anti-parasitic treatment, and watch & wait, have ‘‘evolved’’ over decades, and been recently summarized, but without adequate comparative evaluation of efficacy, effectiveness, rate of adverse events, relapse rates, and cost. Clinical decision making is on even shakier ground for extrahepatic and extrapulmonary locations, which are rarer and numbers needed to build comparative trials hard to come by. There is an obligation to put at least what we have on an appropriate evidence base by conducting comparative clinical trials at the scale and quality that allow answering these important questions. As one of the expected results, clear criteria for the watch & wait option alone might already save a substantial proportion of patients from unnecessary interventions and save health services money. Difficult chronic diseases clustering in poor rural areas need intelligent, creative approaches, and this one urgently needs operational research incorporating the particularities of resource- poor settings into consideration

Recommendations for change in infection prevention programs and practice

Fifty years of evolution in infection prevention and control programs have involved significant accomplishments related to clinical practices, methodologies, and technology. However, regulatory mandates, and resource and research limitations, coupled with emerging infection threats such as the COVID-19 pandemic, present considerable challenges for infection preventionists. This article provides guidance and recommendations in 14 key areas. These interventions should be considered for implementation by United States health care facilities in the near future